FitLife Brands, Inc. (FTLF) SEC filings

FTLFNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 4/3016% above fair value

$8.30−0.02 (-0.24%)

Close on Nov 12, 2026Market cap $77.95MP/E 43.7Yield –

SEC filings

40 of FitLife Brands's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Current report	8-K	Sep 9, 2026	Sep 9, 2026	SEC EDGAR
Current report	8-K	Aug 11, 2026	Aug 13, 2026	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2026	Aug 13, 2026	SEC EDGAR
Proxy statement	DEF 14A	Aug 11, 2026	Jun 26, 2026	SEC EDGAR
Current report	8-K	May 18, 2026	May 22, 2026	SEC EDGAR
Current report	8-K	May 14, 2026	May 14, 2026	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2026	May 14, 2026	SEC EDGAR
Annual report, amended	10-K/A	Dec 31, 2025	Apr 21, 2026	SEC EDGAR
Current report	8-K	Apr 1, 2026	Apr 7, 2026	SEC EDGAR
Current report	8-K	Apr 1, 2026	Apr 1, 2026	SEC EDGAR
Annual report	10-K	Dec 31, 2025	Mar 31, 2026	SEC EDGAR
Current report	8-K	Dec 10, 2025	Dec 10, 2025	SEC EDGAR
Current report	8-K	Nov 13, 2025	Nov 13, 2025	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2025	Nov 13, 2025	SEC EDGAR
Current report	8-K	Aug 19, 2025	Aug 19, 2025	SEC EDGAR
Current report	8-K	Aug 14, 2025	Aug 14, 2025	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2025	Aug 14, 2025	SEC EDGAR
Current report	8-K	Aug 12, 2025	Aug 13, 2025	SEC EDGAR
Current report	8-K	Aug 8, 2025	Aug 11, 2025	SEC EDGAR
Current report	8-K	Jul 31, 2025	Aug 5, 2025	SEC EDGAR
Proxy statement	DEF 14A	Aug 12, 2025	Jun 24, 2025	SEC EDGAR
Current report	8-K	May 15, 2025	May 15, 2025	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2025	May 15, 2025	SEC EDGAR
Annual report, amended	10-K/A	Dec 31, 2024	Apr 29, 2025	SEC EDGAR
Current report	8-K	Apr 25, 2025	Apr 28, 2025	SEC EDGAR
Current report	8-K	Apr 22, 2025	Apr 22, 2025	SEC EDGAR
Current report	8-K	Mar 27, 2025	Mar 27, 2025	SEC EDGAR
Annual report	10-K	Dec 31, 2024	Mar 27, 2025	SEC EDGAR
Current report	8-K	Mar 13, 2025	Mar 13, 2025	SEC EDGAR
Current report	8-K	Feb 5, 2025	Feb 5, 2025	SEC EDGAR
Current report	8-K	Dec 16, 2024	Dec 16, 2024	SEC EDGAR
Current report	8-K	Nov 18, 2024	Nov 18, 2024	SEC EDGAR
Current report	8-K	Nov 14, 2024	Nov 14, 2024	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2024	Nov 14, 2024	SEC EDGAR
Current report	8-K	Aug 13, 2024	Aug 14, 2024	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2024	Aug 14, 2024	SEC EDGAR
Proxy statement	DEF 14A	Aug 13, 2024	Jul 5, 2024	SEC EDGAR
Current report	8-K	Jul 3, 2024	Jul 5, 2024	SEC EDGAR
Current report	8-K	May 14, 2024	May 14, 2024	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2024	May 14, 2024	SEC EDGAR

Where these numbers come from

Parsed from the XBRL in FitLife Brands's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Feb 7, 2025
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is FTLF.

Compare: FTLF vs MTEX · FTLF vs NAII · FTLF vs SNYRQ · FTLF vs NAGE · FTLF vs BTMD

Gross margin12.3% · median 65.4%

Operating margin3.8% · median 0.9%

Net margin1.9% · median -1.1%

Company	Revenue	Growth
BTMD	$178.91M	-8.6%
NAII	$142.52M	+9.7%
NAGE	$122.29M	-1.9%
MTEX	$103.07M	-6.6%
FTLF	$101.27M	–
SNYRQ	$27.70M	-17.5%

Company

Exchange: Nasdaq
Industry: Medicinal Chemicals & Botanical Products
Fiscal year ends: December 31
Employees: 39
Held by institutions: 6.8%
Auditor: Weinberg & Company, P.A.
SEC CIK: 1374328

Advertisement
300 × 250

See a number that looks wrong?